Shanghai Sipeng Technology

About Shanghai Sipeng Technology

Shanghai Sipeng Technology, established in 2022, is a company operating at the intersection of synthetic biology and advanced materials. The enterprise was incubated by the Laboratory of Microbial Metabolism at Shanghai Jiaotong University, positioning it with a strong foundation in scientific research.

The firm's core business involves the development and provision of bio-based products derived from synthetic biology processes. It has developed a proprietary negative carbon intelligent manufacturing platform for bio-based materials, signaling its focus on sustainable production methods. The company's revenue is generated through a dual approach of offering specialized synthetic biology technology services and the direct sale of its manufactured bio-based products.

The product pipeline is centered on creating negative carbon new materials, polymer monomers, and various high-value compounds. These materials are designed for application across a diverse set of industries, including polyester manufacturing, cosmetics, agriculture, and medicine. Since its inception, the company has progressed through several key funding stages, securing a seed round in November 2022, followed by early-stage venture capital. A significant milestone was the pre-series A funding of approximately CNY 100 million in October 2024, aimed at scaling up mass production and commercial promotion of its products. This was followed by a pre-series A+ round in May 2025, with total funding reaching a reported $14.2 million from investors such as Fortera Capital, SDIC Unity Capital, CAS Star, and 3E Bioventures Capital.